Search research articles
Contact Us
Filters
Showing results (61-70 of 90) with videos related to
Page
of 9
Sort By:
Cytokine
|
November 1, 1993
Antilipid A monoclonal antibody HA-1A decreases the capacity of bacterial lipopolysaccharide to activate human vascular endothelial cells by an immune adherence mechanism
E M Paleolog, P Katsikis, G Harris, et al.
Infection and Immunity
|
February 1, 1993
Antibiotics enhance binding by human lipid A-reactive monoclonal antibody HA-1A to smooth gram-negative bacteria
S A Siegel, M E Evans, M Pollack, et al.
Clinical Oral Implants Research
|
March 1, 2013
Clinical, microbiological, and salivary biomarker profiles of dental implant patients with type 2 diabetes
Nikolaos Tatarakis, Janet S Kinney, Marita Inglehart, et al.
The New England Journal of Medicine
|
October 19, 2010
Teriparatide and osseous regeneration in the oral cavity
Jill D Bashutski, Robert M Eber, Janet S Kinney, et al.
Journal of Dental Research
|
May 11, 2011
The impact of vitamin D status on periodontal surgery outcomes
J D Bashutski, R M Eber, J S Kinney, et al.
Clinical Advances in Periodontics
|
November 4, 2015
Systemic Teriparatide Administration Promotes Osseous Regeneration of an Intrabony Defect: A Case Report
Jill D Bashutski, Janet S Kinney, Erika Benavides, et al.
The Pediatric Infectious Disease Journal
|
July 1, 1993
Outbreak of early onset group B streptococcal sepsis
W G Adams, J S Kinney, A Schuchat, et al.
Journal of Clinical Periodontology
|
January 29, 2016
Effects of triclosan on host response and microbial biomarkers during experimental gingivitis
Brooke A Pancer, Diana Kott, James V Sugai, et al.
Cytokine
|
July 1, 1993
Antilipid a monoclonal antibody HA-1A: immune complex clearance of endotoxin reduces TNF-alpha, IL-1 beta and IL-6 production
P Katsikis, G Harris, T Page, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
August 17, 2001
Efficacy and safety of orally/sublingually, intranasally, and intraperitoneally administered recombinant murine interferon in the treatment of murine encephalomyocarditis virus
G Sonnenfeld, M Tovey, H Schellekens, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 90) with videos related to
Sort By:
Page
of 9
Cytokine
|
November 1, 1993
Antilipid A monoclonal antibody HA-1A decreases the capacity of bacterial lipopolysaccharide to activate human vascular endothelial cells by an immune adherence mechanism
E M Paleolog, P Katsikis, G Harris, et al.
Infection and Immunity
|
February 1, 1993
Antibiotics enhance binding by human lipid A-reactive monoclonal antibody HA-1A to smooth gram-negative bacteria
S A Siegel, M E Evans, M Pollack, et al.
Clinical Oral Implants Research
|
March 1, 2013
Clinical, microbiological, and salivary biomarker profiles of dental implant patients with type 2 diabetes
Nikolaos Tatarakis, Janet S Kinney, Marita Inglehart, et al.
The New England Journal of Medicine
|
October 19, 2010
Teriparatide and osseous regeneration in the oral cavity
Jill D Bashutski, Robert M Eber, Janet S Kinney, et al.
Journal of Dental Research
|
May 11, 2011
The impact of vitamin D status on periodontal surgery outcomes
J D Bashutski, R M Eber, J S Kinney, et al.
Clinical Advances in Periodontics
|
November 4, 2015
Systemic Teriparatide Administration Promotes Osseous Regeneration of an Intrabony Defect: A Case Report
Jill D Bashutski, Janet S Kinney, Erika Benavides, et al.
The Pediatric Infectious Disease Journal
|
July 1, 1993
Outbreak of early onset group B streptococcal sepsis
W G Adams, J S Kinney, A Schuchat, et al.
Journal of Clinical Periodontology
|
January 29, 2016
Effects of triclosan on host response and microbial biomarkers during experimental gingivitis
Brooke A Pancer, Diana Kott, James V Sugai, et al.
Cytokine
|
July 1, 1993
Antilipid a monoclonal antibody HA-1A: immune complex clearance of endotoxin reduces TNF-alpha, IL-1 beta and IL-6 production
P Katsikis, G Harris, T Page, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
August 17, 2001
Efficacy and safety of orally/sublingually, intranasally, and intraperitoneally administered recombinant murine interferon in the treatment of murine encephalomyocarditis virus
G Sonnenfeld, M Tovey, H Schellekens, et al.
Page
of 9